Eli Lilly's weight loss drug reduces sleep apnea, study shows
Eli Lilly noted that tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive sleep apnea and obesity.
Eli Lily's Mounjaro is more effective for weight loss than Ozempic, study shows
Mounjaro, which is the brand name for tirzepatide, was shown to be even more powerful than Ozempic in a recent study with adults who were overweight or obese.
Eli Lilly, Novo Nordisk test popular weight loss-related drugs on children
Eli Lilly and Novo Nordisk are seeking to test some of their most popular drugs approved for Type 2 diabetes and weight management in adults on children.
FDA calls on Congress to create new regulations for hemp-derived CBD products
The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.
Pfizer's new trial vaccine for RSV is over 85% effective in older adults
Pfizer announced on Thursday that a vaccine designed to stop respiratory syncytial virus, or RSV, infections is over 85% effective in older adults.
Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial
On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.